W. Sauerbrei, P. Royston, and H. Binder. Statistics in medicine, 26 (30):
5512-28(December 2007)4592<m:linebreak></m:linebreak>CI: Copyright (c) 2007; JID: 8215016; 0 (Antineoplastic Agents); ppublish;<m:linebreak></m:linebreak>Anàlisi de dades.
D. MacKinnon, J. Krull, and C. Lockwood. Prevention science : the official journal of the Society for Prevention Research, 1 (4):
173-81(December 2000)3530<m:linebreak></m:linebreak>Mesures d'associació.
Y. Roux, C. Guimart, and M. Tenenhaus. European journal of drug metabolism and pharmacokinetics, 23 (2):
339-45(1998)2478<m:linebreak></m:linebreak>Tests d'equivalència.
S. Nakagawa, and I. Cuthill. Biological reviews of the Cambridge Philosophical Society, 82 (4):
591-605(November 2007)5137<m:linebreak></m:linebreak>LR: 20081107; JID: 0414576; RF: 95; ppublish;<m:linebreak></m:linebreak>Tamaño del efecto.
T. Baguley. British journal of psychology (London, England : 1953), 100 (Pt 3):
603-17(August 2009)5362<m:linebreak></m:linebreak>JID: 0373124; 2008/11/17 aheadofprint; ppublish;<m:linebreak></m:linebreak>Tamaño del efecto.
S. Samuelsen, and G. Eide. Statistics in medicine, 27 (9):
1447-67(April 2008)4992<m:linebreak></m:linebreak>CI: 2008; JID: 8215016; ppublish;<m:linebreak></m:linebreak>Risc atribuïble.
S. Xu, C. Ross, M. Raebel, S. Shetterly, C. Blanchette, and D. Smith. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 13 (2):
273-7(January 2010)Mesures d'associació; IPTW; Risc relatiu.